(Q53482190)
Statements
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. (English)
Cohen JA
Fischer JS
Goodman AD
Heidenreich FR
Jak AJ
Kniker JE
Kooijmans MF
Lull JM
Sandrock AW
Simon JH
Simonian NA
Whitaker JN
1 June 2001
58
6
961-967